Attached files
file | filename |
---|---|
EX-31.4 - EX-31.4 - Tobira Therapeutics, Inc. | d253388dex314.htm |
EX-10.2 - EX-10.2 - Tobira Therapeutics, Inc. | d253388dex102.htm |
EX-10.1 - EX-10.1 - Tobira Therapeutics, Inc. | d253388dex101.htm |
10-Q/A - 10-Q/A - Tobira Therapeutics, Inc. | d253388d10qa.htm |
EXHIBIT 31.3
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Laurent Fischer, M.D., certify that:
1. | I have reviewed this Amendment No. 2 to Quarterly Report on Form 10-Q of Tobira Therapeutics, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: September 9, 2016
/s/ Laurent Fischer, M.D. |
Laurent Fischer, M.D. |
Chief Executive Officer (Principal Executive Officer) |